Unknown

Dataset Information

0

Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.


ABSTRACT: OBJECTIVES:There is considerable evidence that implicates dysregulation of type I interferon signalling (or type I IFN signature) in the pathogenesis of systemic sclerosis (SSc). Interferon regulatory factor 7 (IRF7) has been recognised as a master regulator of type I IFN signalling. The objective of this study was to elucidate the role of IRF7 in dermal fibrosis and SSc pathogenesis. METHODS:SSc and healthy control skin biopsies were investigated to determine IRF7 expression and activation. The role of IRF7 in fibrosis was investigated using IRF7 knockout (KO) mice in the bleomycin-induced and TSK/+mouse models. In vitro experiments with dermal fibroblasts from patients with SSc and healthy controls were performed. RESULTS:IRF7 expression was significantly upregulated and activated in SSc skin tissue and explanted SSc dermal fibroblasts compared with unaffected, matched controls. Moreover, IRF7 expression was stimulated by IFN-? in dermal fibroblasts. Importantly, IRF7 co-immunoprecipitated with Smad3, a key mediator of transforming growth factor (TGF)-? signalling, and IRF7 knockdown reduced profibrotic factors in SSc fibroblasts. IRF7 KO mice demonstrated attenuated dermal fibrosis and inflammation compared with wild-type mice in response to bleomycin. Specifically, hydroxyproline content, dermal thickness as well as Col1a2, ACTA2 and interleukin-6 mRNA levels were significantly attenuated in IRF7 KO mice skin tissue. Furthermore, IRF7 KO in TSK/+mice attenuated hydroxyproline content, subcutaneous hypodermal thickness, Col1a2 mRNA as well as ?-smooth muscle actin and fibronectin expression. CONCLUSIONS:IRF7 is upregulated in SSc skin, interacts with Smad3 and potentiates TGF-?-mediated fibrosis, and therefore may represent a promising therapeutic target in SSc.

SUBMITTER: Wu M 

PROVIDER: S-EPMC7167109 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.

Wu Minghua M   Skaug Brian B   Bi Xiongjie X   Mills Tingting T   Salazar Gloria G   Zhou Xiaodong X   Reveille John J   Agarwal Sandeep K SK   Blackburn Michael R MR   Mayes Maureen D MD   Assassi Shervin S  

Annals of the rheumatic diseases 20190822 11


<h4>Objectives</h4>There is considerable evidence that implicates dysregulation of type I interferon signalling (or type I IFN signature) in the pathogenesis of systemic sclerosis (SSc). Interferon regulatory factor 7 (IRF7) has been recognised as a master regulator of type I IFN signalling. The objective of this study was to elucidate the role of IRF7 in dermal fibrosis and SSc pathogenesis.<h4>Methods</h4>SSc and healthy control skin biopsies were investigated to determine IRF7 expression and  ...[more]

Similar Datasets

| S-EPMC6859527 | biostudies-literature
| S-EPMC3509422 | biostudies-literature
| S-EPMC4459100 | biostudies-literature
| S-EPMC6916442 | biostudies-literature
| S-EPMC6790618 | biostudies-literature
| S-EPMC5380226 | biostudies-literature
| S-EPMC7566292 | biostudies-literature
| S-EPMC10219222 | biostudies-literature
2020-02-11 | GSE122305 | GEO
| S-EPMC6857489 | biostudies-literature